Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Schubert-Fritschle

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Deutsches Arzteblatt International|August 26, 2022
Estimation of the Risk of Progression of Breast Cancer After the COVID-19 LockdownDieter Hölzel, Gabriele Schubert-Fritschle, Jutta Engel
Scientific Reports|September 27, 2023
Expanding mammography screening for women aged 40-80 years: evidence from a modeling approach using real-world dataDieter Hölzel, Kathrin Halfter, Gabriele Schubert-Fritschle, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2020
Breast cancer: are long-term and intermittent endocrine therapies equally effective?Jutta Engel, Gabriele Schubert-Fritschle, Rebecca Emeny, et al.
The Lancet Regional Health. Europe|May 8, 2023
Risk of metastasis in breast cancer through delay in start of primary therapyKathrin Halfter, Anne Schlesinger-Raab, Gabriele Schubert-Fritschle, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2022
Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry dataJutta Engel, Renate Eckel, Kathrin Halfter, et al.
Frontiers in Oncology|October 20, 2017
Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel ConceptsGabriele Schubert-Fritschle, Stephanie E Combs, Thomas Kirchner, et al.
International Journal of Behavioral Medicine|July 31, 2013
Quality of life in women with localised breast cancer or malignant melanoma 2 years after initial treatment: a comparisonJutta Engel, Anne Schlesinger-Raab, Rebecca Emeny, et al.
Oncology Research and Treatment|January 31, 2015
Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 yearsMartin Dörr, Dieter Hölzel, Gabriele Schubert-Fritschle, et al.
The Breast Journal|September 23, 2015
Reply to Kowalski C, Wesselmann S, Kuhr K, Wallwiener D, & Kreienberg RSimone Schrodi, Anett Tillack, Antje Niedostatek, et al.
The Breast Journal|July 2, 2015
No Survival Benefit for Patients with Treatment in Certified Breast Centers-A Population-based Evaluation of German Cancer Registry DataSimone Schrodi, Anett Tillack, Antje Niedostatek, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Deutsches Arzteblatt International|August 26, 2022
Estimation of the Risk of Progression of Breast Cancer After the COVID-19 LockdownDieter Hölzel, Gabriele Schubert-Fritschle, Jutta Engel
Scientific Reports|September 27, 2023
Expanding mammography screening for women aged 40-80 years: evidence from a modeling approach using real-world dataDieter Hölzel, Kathrin Halfter, Gabriele Schubert-Fritschle, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2020
Breast cancer: are long-term and intermittent endocrine therapies equally effective?Jutta Engel, Gabriele Schubert-Fritschle, Rebecca Emeny, et al.
The Lancet Regional Health. Europe|May 8, 2023
Risk of metastasis in breast cancer through delay in start of primary therapyKathrin Halfter, Anne Schlesinger-Raab, Gabriele Schubert-Fritschle, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2022
Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry dataJutta Engel, Renate Eckel, Kathrin Halfter, et al.
Frontiers in Oncology|October 20, 2017
Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel ConceptsGabriele Schubert-Fritschle, Stephanie E Combs, Thomas Kirchner, et al.
International Journal of Behavioral Medicine|July 31, 2013
Quality of life in women with localised breast cancer or malignant melanoma 2 years after initial treatment: a comparisonJutta Engel, Anne Schlesinger-Raab, Rebecca Emeny, et al.
Oncology Research and Treatment|January 31, 2015
Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 yearsMartin Dörr, Dieter Hölzel, Gabriele Schubert-Fritschle, et al.
The Breast Journal|September 23, 2015
Reply to Kowalski C, Wesselmann S, Kuhr K, Wallwiener D, & Kreienberg RSimone Schrodi, Anett Tillack, Antje Niedostatek, et al.
The Breast Journal|July 2, 2015
No Survival Benefit for Patients with Treatment in Certified Breast Centers-A Population-based Evaluation of German Cancer Registry DataSimone Schrodi, Anett Tillack, Antje Niedostatek, et al.
Pageof 4